» Articles » PMID: 25184359

Long-term Outcomes After Combined Revascularization Surgery in Adult Moyamoya Disease

Overview
Journal Stroke
Date 2014 Sep 4
PMID 25184359
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The surgical outcomes of adult moyamoya disease are rarely reported. We aimed to evaluate the long-term outcomes of combined revascularization surgery in patients with adult moyamoya disease.

Methods: Combined revascularization surgery consisting of superficial temporal artery-middle cerebral artery anastomosis with encephalodurogaleosynangiosis was performed on 77 hemispheres in 60 patients. Clinical, angiographic, and hemodynamic states were evaluated retrospectively using quantitative methods preoperatively and postoperatively in the short-term (≈6 months) and long-term (≈5 years) periods. The mean clinical follow-up duration was 71.0±10.1 months (range, 60-104 months).

Results: Clinical status improved until 6 months after surgery and remained stable thereafter, as assessed by the Karnofsky Performance Scale and modified Rankin Scale. The revascularization area relative to supratentorial area significantly increased in the long-term period compared with that in the short-term period (54.8% versus 44.2%; P<0.001). Cerebral blood flow in the territory of the middle cerebral artery improved in the short-term period compared with that in the preoperative period (68.7 versus 59.1; considering blood flow of the pons as 50; P<0.001) and thereafter became stable (65.5 in the long term; P=0.219). The annual risks of symptomatic hemorrhage and infarction were 0.4% and 0.2%, respectively, in the operated hemispheres.

Conclusions: Combined revascularization surgery resulted in satisfactory long-term improvement in clinical, angiographic, and hemodynamic states and prevention of recurrent stroke.

Citing Articles

Clinical Outcomes and Stroke Recurrence in Moyamoya Disease Post-Revascularization: A Retrospective Analysis.

Alhumaid A, Taher N, Alanazi R, Bensaeed N J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4628-S4633.

PMID: 40061704 PMC: 11888732. DOI: 10.4103/jpbs.jpbs_1085_24.


Clinical Outcome and Surgical Outcome of Moyamoya Disease after Combined Revascularization Performed at the Neurological Institute of Thailand.

Yuthagovit S, Lertbutsayanuku P, Tirakotai W Asian J Neurosurg. 2025; 20(1):75-81.

PMID: 40041576 PMC: 11875710. DOI: 10.1055/s-0044-1792159.


Reinforcement of Transdural Angiogenesis: A Novel Approach to Treating Ischemic Stroke With Cerebral Perfusion Impairment.

Hong J, Shin H J Stroke. 2025; 27(1):30-40.

PMID: 39916452 PMC: 11834342. DOI: 10.5853/jos.2024.02810.


Enhanced Benefit of STA-MCA Bypass Surgery in Chronic Terminal Internal Carotid and/or Middle Cerebral Artery Occlusion Patients With Impaired Collateral Circulation: Introducing a Novel Assessment Approach for Collateral Compensation.

Qiu C, Zhang Y, Yu Z, Xu Y, Huang Y, Huang T Emerg Med Int. 2025; 2025():5059097.

PMID: 39850264 PMC: 11756939. DOI: 10.1155/emmi/5059097.


Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.

He S, Zhou Z, Cheng M, Hao X, Chiang T, Wang Y MedComm (2020). 2025; 6(2):e70054.

PMID: 39822761 PMC: 11733107. DOI: 10.1002/mco2.70054.